← All companies

ALMR

Alamar Biosciences, Inc.

ALMR Nasdaq Laboratory Analytical Instruments EDGAR ↗

$27.07

+1.71 +6.74%

Key statistics

from XBRL data in SEC filings

Market cap

$1.88B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$64.6M

Total assets

$186M

Gross margin

—

52-week range

$18.85 – $29.43

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 15, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Amended charter or bylaws; Other events Apr 20, 2026

Other filings

SCHEDULE 13D/A Jul 7, 2026 SCHEDULE 13G Jul 2, 2026 SCHEDULE 13D Apr 23, 2026 SCHEDULE 13D Apr 23, 2026 4 Apr 22, 2026 EFFECT Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 4 Apr 20, 2026 S-8 Apr 20, 2026 POS AM Apr 20, 2026 424B4 Apr 17, 2026 EFFECT Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 3 Apr 16, 2026 S-1MEF Apr 16, 2026 CERT Apr 16, 2026 S-1/A Apr 16, 2026 8-A12B Apr 15, 2026 S-1/A Apr 13, 2026 S-1 Mar 27, 2026 DRS/A Mar 12, 2026 DRS/A Feb 17, 2026